Asthma

Asthma is a chronic respiratory condition that inflames and narrows the airways, causing symptoms like wheezing, coughing, chest tightness, and shortness of breath. It can vary in severity and frequency of symptoms from person to person.

Current treatment options for asthma include controller medications and reliever medications. Controller medications such as inhaled corticosteroids and long-acting beta agonists are taken regularly to prevent symptoms. Reliever medications such as short-acting beta agonists are used for quick relief of symptoms during an asthma attack. Biologics are another option that are relatively new to the market. The appeal of biologics is that they do not have to be taken on a daily basis like many options. Rather, biologics typically come in the form of an injection that is given once every few weeks.

We are continually testing new therapies to improve asthma management and address gaps in current treatments. Some of the new therapies we may be exploring include anti-IL-4/IL-13 therapies, IL-33 antagonists, tyrosine kinase inhibitors, prostaglandin D2 receptor antagonists, novel bronchodilators, and many others. These trials are at various stages of clinical trials as we are testing the safety and efficacy of these new therapies. We aim to provide more effective and personalized treatment options for people diagnosed with asthma.